Uscom held an International Video Conference with our distributors from USA, Europe, Middle East, and Asia, discussing how the USCOM 1A Cardiac Output Monitor can be used for patients infected with COVID-19.
USCOM 1A can save COVID-19 patients with early identification of LV dysfunction and precision therapy to preserve DO2. COVID-19 will pass but seasonal infections and sepsis are ever universal threats to health. This pandemic has identified a need to increase equipment levels in ICU’s to support patients with these infections. While there is a focus on ventilation, the majority of patients die from cardiovascular failure so improved CV monitoring is vital, and USCOM 1A is the recommended technology for this.